Project Grant R21AI188037
Award Date
11/15/24
Completion Date
10/31/26
Dollars Obligated
$204K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Burlington, VT 05405, USA
Similar Awards
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $219,122 to the University of Illinois to conduct research on Salmonella Typhimurium infection. The goal is to understand the mechanisms of gene regulation that control the bacteria's ability to infect and colonize host cells. The research focuses on characterizing a novel small RNA-mediated regulatory system that...
The University of Utah was awarded a $728,244 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) to conduct research on the molecular mechanisms of Salmonella's type III secretion system. The goal is to develop a better understanding of how this critical virulence mechanism in Gram-negative pathogens, including Salmonella, Shigella, Vibrio, Pseudomonas, Yersinia, and Chlamydia, selects...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $127,302 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the Regents of the University of Michigan. The grant, awarded on January 18, 2025, supports research to understand how the integrated stress response (ISR) in macrophages shapes the innate immune response and infection outcomes during Salmonella enterica serovar Typhi (STy) infection. The research aims to reveal the role of...
This $531,245 Project Grant awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) will fund research by Yale University to structurally and functionally characterize the sorting platform component of the type III secretion system (T3SS) in Salmonella bacteria. Through a multidisciplinary approach involving bacterial genetics, biochemistry, microscopy, and cryo-electron microscopy, the research aims to...
This $4,004,843 Cooperative Agreement award, provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research Federal Grant Program (CFDA 93.855), aims to advance the understanding of systemic and mucosal immunity to enteric bacterial pathogens like Salmonella and Shigella in children and adults. The award supports research projects that will use human-based models and specimens from clinical studies to examine the immunological...
The University of California, Davis received a $225,839 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The award, titled "Vaccine Induction of Salmonella-Specific Th1 Memory Cells," aims to investigate the role of tissue-resident memory CD4 T cells in providing protection against systemic Salmonella infections, and to evaluate the use of an mRNA nanoparticle vaccine...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of Vermont & State Agricultural College (UVM) in the amount of $438,983. The award, which runs from July 8, 2025 to June 30, 2027, will fund research to study the biological impact of a stable nucleocapsid (N) protein dimer formation in SARS-CoV-2. Specifically, the research aims to characterize viral growth...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $422,125 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of Florida. The grant will fund research to develop a Salmonella-based vaccine that can deliver Francisella type VI secretion system proteins as antigens to induce protective immunity against tularemia, a potentially deadly infectious disease. The research aims to leverage an established Salmonella antigen...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $408,865 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of Vermont & State Agricultural College. The grant supports the development of new tools to study how the protozoan parasite Toxoplasma gondii delivers its "rhoptry effector" proteins into host cells during the invasion process. The goals are to: 1) Develop an assay to test whether the rhoptry...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $152,656 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of Colorado-Denver. The grant, titled "Synaptopodin and Its Role in Shigella flexneri Intercellular Spread," will fund research to investigate the molecular mechanisms by which the protein synaptopodin promotes the ability of the Shigella bacteria to spread between cells, a critical process for...